Showing results (441-450 of 472) with videos related to
Sort By:
Pageof 48
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2018
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled TrialMahasweta Gooptu, Haesook T Kim, Yi-Bin Chen, et al.Blood|August 17, 2012
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathwaysJessica L Allen, Matthew S Fore, Jenna Wooten, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502Steven M Devine, Kouros Owzar, William Blum, et al.Developmental Biology|March 26, 2003
ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheetsPaul W Wright, Laura C Bolling, Meredith E Calvert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignanciesRobert Z Orlowski, Thomas E Stinchcombe, Beverly S Mitchell, et al.Blood|August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaKoen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.British Journal of Haematology|December 20, 2016
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106Robert W Chen, Hongli Li, Steven H Bernstein, et al.The Lancet. Haematology|March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 studyNatalie S Grover, George Hucks, Marcie L Riches, et al.Leukemia & Lymphoma|January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysisZeina Al-Mansour, Hongli Li, James R Cook, et al.The New England Journal of Medicine|November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaPatrick J Stiff, Joseph M Unger, James R Cook, et al.Pageof 48